Photoactivable Glycolipid Antigens Generate Stable Conjugates with CD1d for Invariant Natural Killer T Cell Activation

Natacha Veerapen, Shalu Sharma, Peter Jervis, Veemal Bhowruth, Amareeta K. Besra, Simon J. North, Stuart M. Haslam, Anne Dell, Judith Hobrath, Padraic J. Quaid, Patrick J. Moynihan, Liam R. Cox, Himanshu Kharkwal, Maurice Zauderer, Gurdyal S. Besra, Steven A. Porcelli

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Activation of invariant natural killer T lymphocytes (iNKT cells) by α-galactosylceramide (α-GC) elicits a range of pro-inflammatory or anti-inflammatory immune responses. We report the synthesis and characterization of a series of α-GC analogues with acyl chains of varying length and a terminal benzophenone. These bound efficiently to the glycolipid antigen presenting protein CD1d, and upon photoactivation formed stable CD1d-glycolipid covalent conjugates. Conjugates of benzophenone α-GCs with soluble or cell-bound CD1d proteins retained potent iNKT cell activating properties, with biologic effects that were modulated by acyl chain length and the resulting affinities of conjugates for iNKT cell antigen receptors. Analysis by mass spectrometry identified a unique covalent attachment site for the glycolipid ligands in the hydrophobic ligand binding pocket of CD1d. The creation of covalent conjugates of CD1d with α-GC provides a new tool for probing the biology of glycolipid antigen presentation, as well as opportunities for developing effective immunotherapeutics.

Original languageEnglish (US)
Pages (from-to)3161-3173
Number of pages13
JournalBioconjugate Chemistry
Volume29
Issue number9
DOIs
StatePublished - Sep 19 2018

Fingerprint

Natural Killer T-Cells
T-cells
Glycolipids
Antigens
Chemical activation
Ligands
Galactosylceramides
Proteins
Antigen Receptors
Antigen Presentation
Chain length
Mass spectrometry
Mass Spectrometry
Anti-Inflammatory Agents
T-Lymphocytes
benzophenone

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering
  • Pharmacology
  • Pharmaceutical Science
  • Organic Chemistry

Cite this

Photoactivable Glycolipid Antigens Generate Stable Conjugates with CD1d for Invariant Natural Killer T Cell Activation. / Veerapen, Natacha; Sharma, Shalu; Jervis, Peter; Bhowruth, Veemal; Besra, Amareeta K.; North, Simon J.; Haslam, Stuart M.; Dell, Anne; Hobrath, Judith; Quaid, Padraic J.; Moynihan, Patrick J.; Cox, Liam R.; Kharkwal, Himanshu; Zauderer, Maurice; Besra, Gurdyal S.; Porcelli, Steven A.

In: Bioconjugate Chemistry, Vol. 29, No. 9, 19.09.2018, p. 3161-3173.

Research output: Contribution to journalArticle

Veerapen, N, Sharma, S, Jervis, P, Bhowruth, V, Besra, AK, North, SJ, Haslam, SM, Dell, A, Hobrath, J, Quaid, PJ, Moynihan, PJ, Cox, LR, Kharkwal, H, Zauderer, M, Besra, GS & Porcelli, SA 2018, 'Photoactivable Glycolipid Antigens Generate Stable Conjugates with CD1d for Invariant Natural Killer T Cell Activation', Bioconjugate Chemistry, vol. 29, no. 9, pp. 3161-3173. https://doi.org/10.1021/acs.bioconjchem.8b00484
Veerapen, Natacha ; Sharma, Shalu ; Jervis, Peter ; Bhowruth, Veemal ; Besra, Amareeta K. ; North, Simon J. ; Haslam, Stuart M. ; Dell, Anne ; Hobrath, Judith ; Quaid, Padraic J. ; Moynihan, Patrick J. ; Cox, Liam R. ; Kharkwal, Himanshu ; Zauderer, Maurice ; Besra, Gurdyal S. ; Porcelli, Steven A. / Photoactivable Glycolipid Antigens Generate Stable Conjugates with CD1d for Invariant Natural Killer T Cell Activation. In: Bioconjugate Chemistry. 2018 ; Vol. 29, No. 9. pp. 3161-3173.
@article{ec962d3e79c54e43aab46be48bb492db,
title = "Photoactivable Glycolipid Antigens Generate Stable Conjugates with CD1d for Invariant Natural Killer T Cell Activation",
abstract = "Activation of invariant natural killer T lymphocytes (iNKT cells) by α-galactosylceramide (α-GC) elicits a range of pro-inflammatory or anti-inflammatory immune responses. We report the synthesis and characterization of a series of α-GC analogues with acyl chains of varying length and a terminal benzophenone. These bound efficiently to the glycolipid antigen presenting protein CD1d, and upon photoactivation formed stable CD1d-glycolipid covalent conjugates. Conjugates of benzophenone α-GCs with soluble or cell-bound CD1d proteins retained potent iNKT cell activating properties, with biologic effects that were modulated by acyl chain length and the resulting affinities of conjugates for iNKT cell antigen receptors. Analysis by mass spectrometry identified a unique covalent attachment site for the glycolipid ligands in the hydrophobic ligand binding pocket of CD1d. The creation of covalent conjugates of CD1d with α-GC provides a new tool for probing the biology of glycolipid antigen presentation, as well as opportunities for developing effective immunotherapeutics.",
author = "Natacha Veerapen and Shalu Sharma and Peter Jervis and Veemal Bhowruth and Besra, {Amareeta K.} and North, {Simon J.} and Haslam, {Stuart M.} and Anne Dell and Judith Hobrath and Quaid, {Padraic J.} and Moynihan, {Patrick J.} and Cox, {Liam R.} and Himanshu Kharkwal and Maurice Zauderer and Besra, {Gurdyal S.} and Porcelli, {Steven A.}",
year = "2018",
month = "9",
day = "19",
doi = "10.1021/acs.bioconjchem.8b00484",
language = "English (US)",
volume = "29",
pages = "3161--3173",
journal = "Bioconjugate Chemistry",
issn = "1043-1802",
publisher = "American Chemical Society",
number = "9",

}

TY - JOUR

T1 - Photoactivable Glycolipid Antigens Generate Stable Conjugates with CD1d for Invariant Natural Killer T Cell Activation

AU - Veerapen, Natacha

AU - Sharma, Shalu

AU - Jervis, Peter

AU - Bhowruth, Veemal

AU - Besra, Amareeta K.

AU - North, Simon J.

AU - Haslam, Stuart M.

AU - Dell, Anne

AU - Hobrath, Judith

AU - Quaid, Padraic J.

AU - Moynihan, Patrick J.

AU - Cox, Liam R.

AU - Kharkwal, Himanshu

AU - Zauderer, Maurice

AU - Besra, Gurdyal S.

AU - Porcelli, Steven A.

PY - 2018/9/19

Y1 - 2018/9/19

N2 - Activation of invariant natural killer T lymphocytes (iNKT cells) by α-galactosylceramide (α-GC) elicits a range of pro-inflammatory or anti-inflammatory immune responses. We report the synthesis and characterization of a series of α-GC analogues with acyl chains of varying length and a terminal benzophenone. These bound efficiently to the glycolipid antigen presenting protein CD1d, and upon photoactivation formed stable CD1d-glycolipid covalent conjugates. Conjugates of benzophenone α-GCs with soluble or cell-bound CD1d proteins retained potent iNKT cell activating properties, with biologic effects that were modulated by acyl chain length and the resulting affinities of conjugates for iNKT cell antigen receptors. Analysis by mass spectrometry identified a unique covalent attachment site for the glycolipid ligands in the hydrophobic ligand binding pocket of CD1d. The creation of covalent conjugates of CD1d with α-GC provides a new tool for probing the biology of glycolipid antigen presentation, as well as opportunities for developing effective immunotherapeutics.

AB - Activation of invariant natural killer T lymphocytes (iNKT cells) by α-galactosylceramide (α-GC) elicits a range of pro-inflammatory or anti-inflammatory immune responses. We report the synthesis and characterization of a series of α-GC analogues with acyl chains of varying length and a terminal benzophenone. These bound efficiently to the glycolipid antigen presenting protein CD1d, and upon photoactivation formed stable CD1d-glycolipid covalent conjugates. Conjugates of benzophenone α-GCs with soluble or cell-bound CD1d proteins retained potent iNKT cell activating properties, with biologic effects that were modulated by acyl chain length and the resulting affinities of conjugates for iNKT cell antigen receptors. Analysis by mass spectrometry identified a unique covalent attachment site for the glycolipid ligands in the hydrophobic ligand binding pocket of CD1d. The creation of covalent conjugates of CD1d with α-GC provides a new tool for probing the biology of glycolipid antigen presentation, as well as opportunities for developing effective immunotherapeutics.

UR - http://www.scopus.com/inward/record.url?scp=85052403382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052403382&partnerID=8YFLogxK

U2 - 10.1021/acs.bioconjchem.8b00484

DO - 10.1021/acs.bioconjchem.8b00484

M3 - Article

VL - 29

SP - 3161

EP - 3173

JO - Bioconjugate Chemistry

JF - Bioconjugate Chemistry

SN - 1043-1802

IS - 9

ER -